# MICCAI论文实验表格汇总
## Bio-COT 3.2: 多中心多模态宫颈病变诊断

---

## 📊 Table 1: Comparison with State-of-the-Art Methods

**目的**：验证Bio-COT 3.2相对于现有SOTA方法的优势

| Method | Internal Val AUC | External Test AUC | Sensitivity | Specificity | F1-Score | Params (M) |
|:-------|-----------------:|------------------:|------------:|------------:|---------:|-----------:|
| **Bio-COT 3.2 (Ours)** | **0.XXX ± 0.XXX** | **0.XXX ± 0.XXX** | **0.XXX** | **0.XXX** | **0.XXX** | **XX.X** |
| MedCLIP | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |
| ConVIRT | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |
| mmFormer | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |
| BioMedCLIP | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |
| MATR | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |
| Swin-T + Fusion | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |
| Simple Fusion | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX | 0.XXX | 0.XXX | XX.X |

**说明**：
- 所有方法运行5次（不同随机种子），报告均值±标准差
- 显著性标记：`*` p<0.05, `**` p<0.01, `***` p<0.001 vs Bio-COT 3.2
- **关键发现**：Bio-COT 3.2在外部测试集上显著优于所有SOTA方法

---

## 📊 Table 2: Ablation Studies on Core Components

**目的**：验证3个核心组件的必要性（对应3个研究问题）

| Method | Internal Val AUC | External Test AUC | Δ AUC (vs Full) | Description |
|:-------|-----------------:|------------------:|----------------:|:------------|
| **Bio-COT 3.2 (Full)** | **0.XXX ± 0.XXX** | **0.XXX ± 0.XXX** | - | Complete model with all components |
| **w/o Multi-Modal Fusion** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | -0.XXX | Replace AMCG+NA-mHC with simple concatenation |
| **w/o Cross-Center Adaptation** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | -0.XXX | Remove center-specific noise modeling in NA-mHC |
| **w/o VLM Knowledge** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | -0.XXX | Remove Frozen VLM + Adapter + Visual Notes |

**说明**：
- **消融1 (RQ1)**：验证自适应多模态融合机制（AMCG + NA-mHC）的必要性
- **消融2 (RQ2)**：验证显式建模中心差异对跨中心泛化的重要性
- **消融3 (RQ3)**：验证医学知识整合（VLM）对诊断性能的提升
- 所有实验运行5次，报告均值±标准差

---

## 📊 Table 3: Cross-Center Generalization Analysis

**目的**：验证Bio-COT 3.2在不同医疗中心上的泛化能力

| Center | Train/Val | Test | Bio-COT 3.2 AUC | MedCLIP AUC | ConVIRT AUC | mmFormer AUC |
|:-------|:---------:|:----:|----------------:|-----------:|-----------:|-------------:|
| **Enshi** | ✓ | - | **0.XXX ± 0.XXX** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX |
| **Wuda** | ✓ | - | **0.XXX ± 0.XXX** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX |
| **Xiangyang** | ✓ | - | **0.XXX ± 0.XXX** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX |
| **Jingzhou** | - | ✓ | **0.XXX ± 0.XXX** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX |
| **Shiyan** | - | ✓ | **0.XXX ± 0.XXX** | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX |

**说明**：
- ✓ 表示该中心参与训练/验证
- - 表示该中心不参与训练（仅测试）
- **关键发现**：Bio-COT 3.2在外部测试集（Jingzhou + Shiyan）上保持高性能

---

## 📊 Table 4: Modality Importance Analysis

**目的**：验证多模态（OCT + Colposcopy + Clinical）的必要性

| Modality Combination | Internal Val AUC | External Test AUC | Description |
|:---------------------|-----------------:|------------------:|:------------|
| OCT only | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | Only OCT images |
| Colposcopy only | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | Only colposcopy images |
| Clinical only | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | Only clinical features (HPV+TCT+Age) |
| OCT + Colposcopy | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | Two visual modalities |
| OCT + Clinical | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | OCT + clinical features |
| Colposcopy + Clinical | 0.XXX ± 0.XXX | 0.XXX ± 0.XXX | Colposcopy + clinical features |
| **OCT + Colposcopy + Clinical (Full)** | **0.XXX ± 0.XXX** | **0.XXX ± 0.XXX** | All three modalities |

**说明**：
- 验证每个模态的贡献
- 证明多模态融合的必要性
- **关键发现**：三模态融合显著优于单模态或双模态

---

## 📊 LaTeX表格代码

### Table 1: Comparison with SOTA

```latex
\begin{table}[t]
\centering
\caption{Comparison with state-of-the-art methods on the five-center multimodal cervical lesion dataset.}
\label{tab:comparison_sota}
\resizebox{\textwidth}{!}{%
\begin{tabular}{lcccccc}
\toprule
Method & Internal Val AUC & External Test AUC & Sensitivity & Specificity & F1-Score & Params (M) \\
\midrule
Bio-COT 3.2 (Ours) & \textbf{0.XXX $\pm$ 0.XXX} & \textbf{0.XXX $\pm$ 0.XXX} & \textbf{0.XXX} & \textbf{0.XXX} & \textbf{0.XXX} & \textbf{XX.X} \\
MedCLIP & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX & 0.XXX & 0.XXX & 0.XXX & XX.X \\
ConVIRT & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX & 0.XXX & 0.XXX & 0.XXX & XX.X \\
mmFormer & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX & 0.XXX & 0.XXX & 0.XXX & XX.X \\
\bottomrule
\end{tabular}%
}
\end{table}
```

### Table 2: Ablation Studies

```latex
\begin{table}[t]
\centering
\caption{Ablation studies on three core components of Bio-COT 3.2.}
\label{tab:ablation_studies}
\resizebox{\textwidth}{!}{%
\begin{tabular}{lccc}
\toprule
Method & Internal Val AUC & External Test AUC & $\Delta$ AUC (vs Full) \\
\midrule
Bio-COT 3.2 (Full) & \textbf{0.XXX $\pm$ 0.XXX} & \textbf{0.XXX $\pm$ 0.XXX} & - \\
w/o Multi-Modal Fusion & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX & -0.XXX \\
w/o Cross-Center Adaptation & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX & -0.XXX \\
w/o VLM Knowledge & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX & -0.XXX \\
\bottomrule
\end{tabular}%
}
\end{table}
```

### Table 3: Cross-Center Generalization

```latex
\begin{table}[t]
\centering
\caption{Cross-center generalization performance on each medical center.}
\label{tab:cross_center}
\resizebox{\textwidth}{!}{%
\begin{tabular}{lccccc}
\toprule
Center & Train/Val & Test & Bio-COT 3.2 AUC & MedCLIP AUC & ConVIRT AUC \\
\midrule
Enshi & $\checkmark$ & - & \textbf{0.XXX $\pm$ 0.XXX} & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Wuda & $\checkmark$ & - & \textbf{0.XXX $\pm$ 0.XXX} & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Xiangyang & $\checkmark$ & - & \textbf{0.XXX $\pm$ 0.XXX} & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Jingzhou & - & $\checkmark$ & \textbf{0.XXX $\pm$ 0.XXX} & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Shiyan & - & $\checkmark$ & \textbf{0.XXX $\pm$ 0.XXX} & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
\bottomrule
\end{tabular}%
}
\end{table}
```

### Table 4: Modality Importance

```latex
\begin{table}[t]
\centering
\caption{Modality importance analysis with different modality combinations.}
\label{tab:modality_importance}
\resizebox{\textwidth}{!}{%
\begin{tabular}{lcc}
\toprule
Modality Combination & Internal Val AUC & External Test AUC \\
\midrule
OCT only & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Colposcopy only & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Clinical only & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
OCT + Colposcopy & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
OCT + Clinical & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
Colposcopy + Clinical & 0.XXX $\pm$ 0.XXX & 0.XXX $\pm$ 0.XXX \\
OCT + Colposcopy + Clinical (Full) & \textbf{0.XXX $\pm$ 0.XXX} & \textbf{0.XXX $\pm$ 0.XXX} \\
\bottomrule
\end{tabular}%
}
\end{table}
```

---

## ✅ 实验执行检查清单

### 必须完成的实验

#### 对比实验（Table 1）
- [ ] MedCLIP - 运行5次
- [ ] ConVIRT - 运行5次
- [ ] mmFormer - 运行5次
- [ ] Swin-T + Fusion - 运行5次
- [ ] Bio-COT 3.2 (Full) - 运行5次

#### 消融实验（Table 2）- **仅3个**
- [ ] **w/o Multi-Modal Fusion** - 运行5次
- [ ] **w/o Cross-Center Adaptation** - 运行5次
- [ ] **w/o VLM Knowledge** - 运行5次

#### 跨中心分析（Table 3）
- [ ] 按中心分组评估（所有方法）

#### 模态重要性分析（Table 4）- 可选但推荐
- [ ] 7种模态组合实验

---

## 📝 论文写作要点

### 实验章节结构建议

1. **Section 4.1: Experimental Setup**
   - Dataset description
   - Implementation details
   - Evaluation metrics
   - Statistical analysis methods

2. **Section 4.2: Comparison with State-of-the-Art Methods**
   - Table 1: Main comparison results
   - Key findings and discussion

3. **Section 4.3: Ablation Studies**
   - Table 2: Ablation results
   - Analysis of each component's contribution

4. **Section 4.4: Cross-Center Generalization Analysis**
   - Table 3: Center-wise performance
   - Discussion on generalization ability

5. **Section 4.5: Modality Importance Analysis** (Optional)
   - Table 4: Modality combinations
   - Discussion on multi-modal fusion

---

**生成时间**：2026-01-23  
**版本**：V2.0（优化版，仅3个消融实验）

